Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
4D Molecular Therapeutics, Inc. (FDMT) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A JANUS HENDERSON GROUP PLC reports a 4.5% stake in 4D Molecular Therapeutics, Inc.
02/08/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/31/2023 SC 13G/A BlackRock Inc. reports a 7.7% stake in 4D Molecular Therapeutics Inc.
06/21/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2022 SC 13G/A VIKING GLOBAL INVESTORS LP reports a 12.3% stake in 4D Molecular Therapeutics, Inc.
02/14/2022 SC 13G/A Kirn David reports a 6.3% stake in 4D Molecular Therapeutics Inc.
02/14/2022 SC 13G/A SCHAFFER DAVID reports a 2.8% stake in 4D Molecular Therapeutics Inc.
02/14/2022 SC 13G/A Deep Track Capital, LP reports a 5.9% stake in 4D MOLECULAR THERAPEUTICS, INC.
02/11/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/16/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/12/2021 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy